Clinical trial
A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer
NCT02012920
Study timeline
Study start (actual)2011-12-01Date precision: month
Registry last updated2019-02-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Castration-resistant Prostate Cancerunresolved
CRPCunresolved
Interventions
Sponsors & collaborators
Innocrin Pharmaceuticallead sponsor
Mapped research locations
HoustonTexas, United States1DallasTexas, United States1LondonUnited Kingdom1TampaFlorida, United States1DurhamNorth Carolina, United States1OmahaNebraska, United States1Las VegasNevada, United States1CharlestonSouth Carolina, United States1The BronxNew York, United States1MadisonWisconsin, United States1AthensGreece1WichitaKansas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02012920 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.